Peptidstar Therapeutics
- Biotech or pharma, therapeutic R&D
PeptidStar Therapeutics is a biotech currently based in Shanghai, The company focuses on developing novel cyclopeptide therapeutics to treat autoimmune diseases and as peptide-drug conjugates to cure solid tumors. Especially, PeptidStar is actively developing cyclopeptides as oral alternatives to blockbuster injectable antibody therapies in autoimmune. This new modality seeks to enhance the treatment experience, improve compliance, and increase drug accessibility. PeptidStar is advancing multiple autoimmune and oncology pipelines to preclinical stages and has established a de novo peptide discovery platform. This platform enables high-efficiency screening of high-quality cyclic peptide hits against any target of interest, forming the essential foundation for developing first-in-class peptide therapeutics. While strengthening internal R&D capabilities, the company actively pursues diverse partnership or collaboration models.
Address
ShanghaiShanghai
China
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}